Institute of Radiological Protection and Nuclear Safety, Fontenay-aux-Roses, France.
Department of Plastic Surgery, Military Hospital of Percy, Clamart, France.
Stem Cells Transl Med. 2018 Aug;7(8):569-582. doi: 10.1002/sctm.17-0267. Epub 2018 May 18.
Cutaneous radiation syndrome has severe long-term health consequences. Because it causes an unpredictable course of inflammatory waves, conventional surgical treatment is ineffective and often leads to a fibronecrotic process. Data about the long-term stability of healed wounds, with neither inflammation nor resumption of fibrosis, are lacking. In this study, we investigated the effect of injections of local autologous bone marrow-derived mesenchymal stromal cells (BM-MSCs), combined with plastic surgery for skin necrosis, in a large-animal model. Three months after irradiation overexposure to the rump, minipigs were divided into three groups: one group treated by simple excision of the necrotic tissue, the second by vascularized-flap surgery, and the third by vascularized-flap surgery and local autologous BM-MSC injections. Three additional injections of the BM-MSCs were performed weekly for 3 weeks. The quality of cutaneous wound healing was examined 1 year post-treatment. The necrotic tissue excision induced a pathologic scar characterized by myofibroblasts, excessive collagen-1 deposits, and inadequate vascular density. The vascularized-flap surgery alone was accompanied by inadequate production of extracellular matrix (ECM) proteins (decorin, fibronectin); the low col1/col3 ratio, associated with persistent inflammatory nodules, and the loss of vascularization both attested to continued immaturity of the ECM. BM-MSC therapy combined with vascularized-flap surgery provided mature wound healing characterized by a col1/col3 ratio and decorin and fibronectin expression that were all similar to that of nonirradiated skin, with no inflammation, and vascular stability. In this preclinical model, vascularized flap surgery successfully and lastingly remodeled irradiated skin only when combined with BM-MSC therapy. Stem Cells Translational Medicine 2018:569-582.
皮肤辐射综合征会导致严重的长期健康后果。由于它会引起不可预测的炎症波,常规的手术治疗无效,且常导致纤维坏死过程。缺乏关于愈合的伤口的长期稳定性的数据,这些伤口既没有炎症也没有重新纤维化。在这项研究中,我们在大型动物模型中研究了局部自体骨髓来源间充质基质细胞(BM-MSCs)注射联合皮瓣成形术治疗皮肤坏死的效果。照射过度暴露臀部后 3 个月,小型猪被分为三组:一组仅切除坏死组织,一组行血管化皮瓣手术,第三组行血管化皮瓣手术和局部自体 BM-MSC 注射。在接下来的 3 周内每周进行 3 次 BM-MSC 的局部注射。在治疗后 1 年检查皮肤伤口愈合的质量。坏死组织切除导致病理性瘢痕形成,其特征为肌成纤维细胞、过度的胶原蛋白-1 沉积和不足的血管密度。单纯血管化皮瓣手术伴有细胞外基质(ECM)蛋白(饰胶蛋白、纤维连接蛋白)的产生不足;低 col1/col3 比值与持续存在的炎症性结节以及血管化的丧失均表明 ECM 仍不成熟。BM-MSC 联合血管化皮瓣手术治疗提供成熟的伤口愈合,其 col1/col3 比值和饰胶蛋白、纤维连接蛋白的表达均与未照射皮肤相似,无炎症,且血管稳定。在这个临床前模型中,只有当联合 BM-MSC 治疗时,血管化皮瓣手术才能成功且持久地重塑照射皮肤。《干细胞转化医学》2018 年:569-582。